STUDIES TO OPTIMIZE THE INVITRO TESTING OF PIPERACILLIN COMBINED WITH TAZOBACTAM (YTR-830)

被引：35

作者：

JONES, RN ^{[1
]}

BARRY, AL ^{[1
]}

机构：

[1] CLIN MICROBIOL INST INC,TUALATIN,OR

来源：

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 1989年 / 12卷 / 06期

关键词：

D O I：

10.1016/0732-8893(89)90084-9

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：495 / 510

页数：16

共 28 条

[1] COMPARATIVE ACTIVITY OF BETA-LACTAMASE INHIBITORS YTR 830, CLAVULANATE, AND SULBACTAM COMBINED WITH BETA-LACTAMS AGAINST BETA-LACTAMASE-PRODUCING ANAEROBES
APPELBAUM, PC
JACOBS, MR
SPANGLER, SK
YAMABE, S
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (05) : 789 - 791
[2] SYNERGY OF AMOXICILLIN COMBINED WITH CLAVULANATE AND YTR 830 IN EXPERIMENTAL INFECTIONS IN MICE
ARONOFF, SC
JACOBS, MR
LABROZZI, PH
YAMABE, S
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 18 (02) : 271 - 276
[3] COMPARATIVE ACTIVITIES OF THE BETA-LACTAMASE INHIBITORS YTR-830, SODIUM CLAVULANATE, AND SULBACTAM COMBINED WITH AMOXICILLIN OR AMPICILLIN
ARONOFF, SC
JACOBS, MR
JOHENNING, S
YAMABE, S
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (04) : 580 - 582
[4] PIPERACILLIN SUSCEPTIBILITY TESTS BY THE SINGLE-DISK AGAR DIFFUSION TECHNIQUE
BARRY, AL
THORNSBERRY, C
BADAL, RE
BAKER, CN
JONES, RN
GERLACH, EH
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1979, 16 (03) : 378 - 385
[5] PROPOSED CHANGES IN INTERPRETIVE CRITERIA AND POTENCY OF AMPICILLIN AND AMPICILLIN-SULBACTAM DISKS FOR SUSCEPTIBILITY TESTS
BARRY, AL
JONES, RN
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1988, 26 (04) : 750 - 754
[6] CRITERIA FOR DISK SUSCEPTIBILITY TESTS AND QUALITY-CONTROL GUIDELINES FOR THE CEFOPERAZONE-SULBACTAM COMBINATION
BARRY, AL
JONES, RN
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1988, 26 (01) : 13 - 17
[7] BETA-LACTAMASE INHIBITORS IN PERSPECTIVE
BUSH, K
SYKES, RB
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1983, 11 (02) : 97 - 107
[8] CP-45,899, A BETA-LACTAMASE INHIBITOR THAT EXTENDS ANTIBACTERIAL SPECTRUM OF BETA-LACTAMS - INITIAL BACTERIOLOGICAL CHARACTERIZATION
ENGLISH, AR
RETSEMA, JA
GIRARD, AE
LYNCH, JE
BARTH, WE
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1978, 14 (03) : 414 - 419
[9] PHARMACOKINETICS OF SULBACTAM IN HUMANS
FOULDS, G
STANKEWICH, JP
MARSHALL, DC
OBRIEN, MM
HAYES, SL
WEIDLER, DJ
MCMAHON, FG
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (05) : 692 - 699
[10] INVITRO ACTIVITY AND DISK SUSCEPTIBILITY OF TIMENTIN - CURRENT STATUS
FUCHS, PC
BARRY, AL
JONES, RN
[J]. AMERICAN JOURNAL OF MEDICINE, 1985, 79 (5B) : 25 - 32

← 1 2 3 →